Your Health, We Care

Home > Photo Wall > Honor and qualification

SPARSENTAN Production Approval

Release date: 2024-07-10 15:30:47     Recommended: 158

10L1036_23 司帕森坦 批文_00.jpg

SPARSENTAN, as a novel angiotensin receptor antagonist, has a unique mechanism of action. It can selectively bind to angiotensin receptors, inhibit vascular contraction and remodeling, thereby lowering blood pressure, reducing renal burden, and protecting renal function.

Company News

Research News

Drug news